NCT06305962 2026-02-19177Lu-anti-PD-L1 sdAb in Metastatic Solid TumorsRadiopharm Theranostics, LtdPhase EARLY_PHASE1 Recruiting30 enrolled
NCT03652077 2021-11-15A Safety and Tolerability Study of INCAGN02390 in Select Advanced MalignanciesIncyte CorporationPhase 1 Completed40 enrolled